We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$80B
AUM Growth
+$3.78B
Cap. Flow
+$2.03B
Cap. Flow %
2.54%
Top 10 Hldgs %
13.93%
Holding
3,241
New
178
Increased
2,105
Reduced
536
Closed
137

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$80.9M
2
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$66M
3
MRK icon
Merck
MRK
+$63.3M
4
PG icon
Procter & Gamble
PG
+$58.4M
5
IBM icon
IBM
IBM
+$54.1M

Sector Composition

Rank Sector Weight
1 Healthcare 13.8%
2 Technology 13.16%
3 Financials 12.69%
4 Industrials 10.65%
5 Consumer Staples 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UCP
3051
DELISTED
UCP, Inc.
UCP
$104K ﹤0.01%
+12,900
New +$98.3K
AGRX
3052
DELISTED
Agile Therapeutics
AGRX
$103K ﹤0.01%
7
NVTR
3053
DELISTED
Nuvectra Corporation Common Stock
NVTR
$102K ﹤0.01%
13,764
-16,764
-55% -$134K
SNDX icon
3054
Syndax Pharmaceuticals
SNDX
$1.82B
$100K ﹤0.01%
+10,100
New +$138K
VHI icon
3055
Valhi
VHI
$450M
$99K ﹤0.01%
5,240
+67
+1% +$1.47K
MRTX
3056
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$99K ﹤0.01%
18,048
PCO
3057
DELISTED
Pendrell Corporation - Class A
PCO
$99K ﹤0.01%
196
-224
-53% -$123K
LWAY icon
3058
Lifeway Foods
LWAY
$481M
$98K ﹤0.01%
10,100
HLTH
3059
DELISTED
Nobilis Health Corp.
HLTH
$97K ﹤0.01%
43,191
EVRI
3060
DELISTED
Everi Holdings
EVRI
$92K ﹤0.01%
79,842
-444,095
-85% -$739K
OCUL icon
3061
Ocular Therapeutix
OCUL
$2.02B
$92K ﹤0.01%
18,570
AMPE
3062
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$92K ﹤0.01%
+235
New +$257K
ADVM
3063
DELISTED
Adverum Biotechnologies
ADVM
$90K ﹤0.01%
2,821
IWD icon
3064
iShares Russell 1000 Value ETF
IWD
$83.9B
$89K ﹤0.01%
+835
New +$84.3K
FUEL
3065
DELISTED
Rocket Fuel Inc.
FUEL
$89K ﹤0.01%
39,667
-25,598
-39% -$67.4K
GEN
3066
DELISTED
Genesis Healthcare, Inc.
GEN
$86K ﹤0.01%
48,100
-29,589
-38% -$60.4K
MDLY
3067
DELISTED
Medley Management Inc
MDLY
$85K ﹤0.01%
1,440
ELDN icon
3068
Eledon Pharmaceuticals
ELDN
$285M
$83K ﹤0.01%
93
-17
-15% -$18.8K
ABCD
3069
DELISTED
Cambium Learning Group, Inc.
ABCD
$82K ﹤0.01%
18,000
LPCN icon
3070
Lipocine
LPCN
$17.6M
$80K ﹤0.01%
+1,535
New +$238K
TSQ icon
3071
Townsquare Media
TSQ
$118M
$80K ﹤0.01%
10,100
CMLS
3072
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$79K ﹤0.01%
31,581
-23,705
-43% -$68.3K
DMTX
3073
DELISTED
Dimension Therapeutics, Inc
DMTX
$79K ﹤0.01%
13,100
DALN
3074
DELISTED
DallasNews
DALN
$70K ﹤0.01%
3,495
HNRG icon
3075
Hallador Energy
HNRG
$696M
$64K ﹤0.01%
13,833
-1,767
-11% -$7.98K

Similar funds

Charles Schwab's Q2 2016 Portfolio in Review

As of Q2 2016, Charles Schwab held 3,241 positions worth $80B, up 5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab's Q2 2016 filing shows 178 new, 2,105 increased, 536 reduced and 137 closed positions. Its largest new stake was S&P Global: 753,915 shares worth $80.9M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $178M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • Charles Schwab's largest Q2 2016 buy was S&P Global: 753,915 shares worth $80.9M.
  • Charles Schwab added most to Merck in Q2 2016, an estimated $63.3M increase.
  • Charles Schwab's biggest Q2 2016 reduction was Computer Sciences, cutting an estimated $61.8M.
  • Charles Schwab fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $178M.
  • Charles Schwab's ten largest holdings make up 14% of its $80B portfolio in Q2 2016.
  • Charles Schwab opened 178 new positions and closed 137 in Q2 2016.
  • Charles Schwab's portfolio value rose 5% quarter-over-quarter to $80B.

Based on Charles Schwab's 13F filing for Q2 2016, filed 15 Aug 2016.